featured
Association of Spironolactone Use With Risk of Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Spironolactone Use With Risk of Cancer: A Systematic Review and Meta-analysis
JAMA Dermatol 2022 Feb 09;[EPub Ahead of Print], K Bommareddy, H Hamade, MA Lopez-Olivo, M Wehner, T Tosh, JS BarbieriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.